# Michael Aldridge

Michael Aldridge is Senior Director of Sales at Carta, driving the global commercial strategy and execution for Carta's LP Portfolio Analytics solution. Previously, he was the Co-founder, President and Chief Revenue Officer of Accelex (acquired by Carta).

## Latest from Michael Aldridge

### [$226B secondaries boom highlights LPs’ needs for better data](/content/uk/en/blog/secondaries-surge-lp-data-needs/index.html)

With secondaries volume reaching an estimated $226 billion in 2025, private market investors face mounting complexity. Only modern data infrastructure can provide the accuracy and transparency LPs need to underwrite high-stakes deals.

### [The audit trail: A fund’s system of record](/content/uk/en/learn/private-funds/management/fund-audits/audit-trail/index.html)

Learn the components of an audit trail and explains why maintaining a complete record is essential for your operational integrity and fiduciary duty.

### [Investor reporting: From compliance to strategy](/content/uk/en/learn/private-funds/management/portfolio-management/investor-reporting/index.html)

Understand the essential components of investor reporting for private funds, including the key performance metrics LPs expect, common operational challenges, and best practices for delivering a modern, transparent experience.

### [Why purpose-built data extraction outpaces DIY for private capital call schedules](/content/uk/en/blog/data-extraction-capital-call-schedules/index.html)

Find out how to solve your capital call challenges with AI in this comprehensive guide to financial data extraction tools.

### [Extracting portfolio company data from PE fund manager reports](/content/uk/en/blog/data-extraction-fund-manager-reports/index.html)

Learn how to extract granular private equity information and PortCo data from fund reports for enhanced portfolio monitoring.

### [Five must-have data points for fund reporting](/content/uk/en/blog/data-extraction-fund-reporting/index.html)

Learn more about the five critical data points that, when used correctly, can significantly impact fund performance and investment outcomes.